tradingkey.logo
tradingkey.logo
Search

Drugs Made In America Acquisition II Ord Shs

DMII
Add to Watchlist
10.095USD
+0.005+0.05%
Close 07-23 16:00ETQuotes delayed by 15 min
643.05MMarket Cap
26.26P/E TTM

Drugs Made In America Acquisition II Ord Shs

10.095
+0.005+0.05%

More Details of Drugs Made In America Acquisition II Ord Shs Company

Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.

Drugs Made In America Acquisition II Ord Shs Info

Ticker SymbolDMII
Company nameDrugs Made In America Acquisition II Corp
IPO dateSep 25, 2025
CEOStockwell (Lynn)
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address1 East Broward Boulevard
CityFT LAUDERDALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33301
Phone19548703099
Website
Ticker SymbolDMII
IPO dateSep 25, 2025
CEOStockwell (Lynn)

Company Executives of Drugs Made In America Acquisition II Ord Shs

Name
Name/Position
Position
Shareholding
Change
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--

FAQs

Who are the top five shareholders of Drugs Made In America Acquisition II Ord Shs?

The top five shareholders of Drugs Made In America Acquisition II Ord Shs are: Dr. Catherine Do
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.